# Vivinex Impress XY1-EM vs RayOne EMV

> **NCT06891092** · NA · RECRUITING · sponsor: **Medical University of Bialystok** · enrollment: 100 (estimated)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** RayOne EMV
- **DEVICE:** Vivinex Impress

## Key facts

- **NCT ID:** NCT06891092
- **Lead sponsor:** Medical University of Bialystok
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06891092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06891092, "Vivinex Impress XY1-EM vs RayOne EMV". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06891092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*